Training scientists to use physical genomics for disease treatment

Physical Genomics and Engineering Training Program

NIH-funded research Northwestern University · NIH-10848301

This program is training future scientists to use a mix of biology and engineering to find new ways to treat diseases like cancer and Alzheimer’s by working with genes, so they can help improve health and farming in the future.

Quick facts

Grant typeTraining grant
Study typeNIH-funded research
Funding institutionNorthwestern University NIH-funded
Lab location1 site (Chicago, UNITED STATES)
Project IDNIH-10848301 on NIH RePORTER

What this research studies

The Physical Genomics Predoctoral Training Program (PGTP) focuses on educating future scientists in the interdisciplinary field of physical genomics, which combines molecular biology, bioengineering, and other sciences. Trainees will learn how to manipulate living systems at a molecular level to develop innovative strategies for treating diseases like cancer and Alzheimer’s. The program emphasizes hands-on experience and collaboration among various scientific disciplines to foster a comprehensive understanding of gene expression regulation. By mastering these techniques, participants will be equipped to contribute to significant advancements in medical and agricultural applications.

Who could benefit from this research

Good fit: Ideal candidates for benefiting from this research include individuals affected by diseases such as cancer and Alzheimer’s, as well as those interested in advancements in agricultural biotechnology.

Not a fit: Patients who are not affected by the targeted diseases or conditions, or those not involved in scientific training, may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to new methods for treating diseases by regulating gene expression without altering genetic material.

How similar studies have performed: While the field of physical genomics is relatively new, there have been promising advancements in related areas of gene regulation and manipulation.

Where this research is happening

Chicago, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.